Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-12 Sale | 2026-06-16 4:42 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $50 | $225,000 | 41,500 (Direct) | View |
| 2026-05-05 Sale | 2026-05-06 8:00 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $46.65 | $209,925 | 37,500 (Direct) | View |
| 2026-05-01 Sale | 2026-05-04 4:27 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,750 | $44.22 | $431,145 | 47,250 (Direct) | View |
| 2026-04-14 Sale | 2026-04-16 4:05 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 32,750 | $41.29 | $1,352,130 | 53,250 (Direct) | View |
| 2026-04-06 Sale | 2026-04-07 6:17 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $33 | $330,000 | 37,500 (Direct) | View |
| 2025-11-19 Sale | 2025-11-21 8:05 pm | Natera Inc. | NTRA | Baynes Roy D. Director | 12,780 | $219.85 | $2,809,689 | 18,959 (Direct) | View |
| 2025-02-06 Sale | 2025-02-10 6:04 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $22 | $220,000 | 31,000 (Direct) | View |
| 2025-01-23 Sale | 2025-01-23 8:36 pm | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $20 | $320,000 | 31,000 (Direct) | View |
| 2024-11-15 Sale | 2024-11-15 9:50 pm | Natera Inc. | NTRA | Baynes Roy D. Director | 37,230 | $146.11 | $5,439,565 | 15,807 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-14 Option Award | 2026-08-21 7:45 pm | N/A 2036-08-14 | Aardvark Therapeutics Inc. | AARD | Baynes Roy D. Director | 44,964 | $0 | 44,964 (Direct) | View |
| 2026-06-26 Option Award | 2026-06-30 8:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 1,646 | $0 | 20,158 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:42 pm | N/A 2032-05-11 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $0 | 41,500 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:42 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $21.38 | 41,500 (Direct) | View |
| 2026-05-19 Option Award | 2026-05-21 5:00 pm | 2027-05-19 2036-05-19 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $0 | 53,500 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:42 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-06 8:00 pm | N/A 2031-05-14 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $0 | 37,500 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-06 8:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $18.27 | 37,500 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-04 4:27 pm | N/A 2034-05-08 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,750 | $0 | 47,250 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-04 4:27 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,750 | $6.82 | 47,250 (Direct) | View |
| 2026-04-24 Option Award | 2026-04-28 8:35 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 83 | $0 | 18,512 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A 2029-05-08 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 32,750 | $0 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 9,000 | $15.43 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 8,000 | $17.94 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $18.27 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 4,500 | $21.38 | 53,250 (Direct) | View |
| 2026-04-14 Exercise | 2026-04-16 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 6,750 | $17.11 | 53,250 (Direct) | View |
| 2026-04-06 Exercise | 2026-04-07 6:17 pm | N/A 2028-05-09 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $0 | 37,500 (Direct) | View |
| 2026-04-06 Exercise | 2026-04-07 6:17 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $26.52 | 37,500 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 4:59 pm | N/A 2036-03-01 | Eikon Therapeutics Inc. | EIKN | Baynes Roy D. Chief Medical Officer | 134,088 | $0 | 134,088 (Direct) | View |
Ownership | 2026-02-04 9:22 pm | N/A 2032-05-30 | Eikon Therapeutics Inc. | EIKN | Baynes Roy D. Chief Medical Officer | 0 | $0 | 268,174 (Direct) | View |
| 2026-01-30 Option Award | 2026-02-03 8:35 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 70 | $0 | 18,429 (Direct) | View |
| 2025-11-19 Exercise | 2025-11-21 8:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 5,712 | $40.93 | 18,959 (Direct) | View |
| 2025-11-19 Exercise | 2025-11-21 8:05 pm | N/A 2030-06-11 | Natera Inc. | NTRA | Baynes Roy D. Director | 12,780 | $0 | 18,959 (Direct) | View |
| 2025-11-20 Exercise | 2025-11-21 8:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 7,068 | $41.19 | 18,959 (Direct) | View |
| 2025-10-31 Option Award | 2025-11-04 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 93 | $0 | 18,359 (Direct) | View |
| 2025-07-25 Option Award | 2025-07-29 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 108 | $0 | 18,266 (Direct) | View |
| 2025-06-27 Option Award | 2025-07-01 9:15 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 2,143 | $0 | 18,158 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Baynes Roy D. Director | 30,508 | $0 | 30,508 (Direct) | View |
| 2025-05-19 Option Award | 2025-05-19 5:32 pm | N/A 2035-05-18 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-16 7:00 pm | 2026-05-15 2035-05-15 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 26,000 | $0 | 57,000 (Direct) | View |
| 2025-04-25 Option Award | 2025-04-29 8:35 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 116 | $0 | 16,015 (Direct) | View |
| 2025-03-11 Option Award | 2025-03-13 4:09 pm | N/A 2035-03-10 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2025-03-13 4:07 pm | N/A 2033-04-10 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 0 | $0 | 10,000 (Direct) | View |
Ownership | 2025-02-12 7:19 pm | N/A 2034-12-17 | Aardvark Therapeutics Inc. | AARD | Baynes Roy D. Director | 0 | $0 | 29,502 (Direct) | View |
| 2025-02-06 Exercise | 2025-02-10 6:04 pm | N/A 2027-05-17 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $0 | 31,000 (Direct) | View |
| 2025-02-06 Exercise | 2025-02-10 6:04 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 10,000 | $17.44 | 31,000 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 9:15 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 92 | $0 | 15,899 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-23 8:36 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $17.5 | 31,000 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-23 8:36 pm | N/A 2026-07-19 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 16,000 | $0 | 31,000 (Direct) | View |
| 2024-11-15 Exercise | 2024-11-15 9:50 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 15,230 | $24.42 | 15,807 (Direct) | View |
| 2024-11-15 Exercise | 2024-11-15 9:50 pm | N/A 2029-05-23 | Natera Inc. | NTRA | Baynes Roy D. Director | 37,230 | $0 | 15,807 (Direct) | View |
| 2024-11-15 Exercise | 2024-11-15 9:50 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 22,000 | $22.83 | 15,807 (Direct) | View |
| 2024-10-25 Option Award | 2024-10-29 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 124 | $0 | 15,807 (Direct) | View |
| 2024-07-26 Option Award | 2024-07-30 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 143 | $0 | 15,683 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 2,964 | $0 | 15,540 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:05 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 26,000 | $0 | 50,500 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-30 8:35 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 169 | $0 | 12,576 (Direct) | View |
| 2024-01-26 Option Award | 2024-01-30 8:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 215 | $63.79 | 12,407 (Direct) | View |
| 2023-10-27 Option Award | 2023-10-31 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 322 | $42.6 | 12,192 (Direct) | View |
| 2023-07-28 Option Award | 2023-08-01 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 264 | $48.48 | 11,870 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:05 pm | N/A 2033-06-08 | Natera Inc. | NTRA | Baynes Roy D. Director | 7,005 | $0 | 15,861 (Direct) | View |
| 2023-05-25 Exercise | 2023-05-26 9:05 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 3,534 | $0 | 8,856 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:06 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 18,000 | $0 | 38,000 (Direct) | View |
| 2023-04-14 Option Award | 2023-04-18 8:10 pm | N/A N/A | Natera Inc. | NTRA | Baynes Roy D. Director | 228 | $54.73 | 5,322 (Direct) | View |